• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Retracted] MicroRNA‑15b promotes proliferation and invasion of non‑small cell lung carcinoma cells by directly targeting TIMP2.[已撤回] 微小RNA-15b通过直接靶向金属蛋白酶组织抑制因子2促进非小细胞肺癌细胞的增殖和侵袭。
Oncol Rep. 2023 Oct;50(4). doi: 10.3892/or.2023.8611. Epub 2023 Aug 18.
2
[Retracted] MicroRNA‑616 promotes the growth and metastasis of non‑small cell lung cancer by targeting SOX7.[已撤回] 微小RNA-616通过靶向SOX7促进非小细胞肺癌的生长和转移。
Oncol Rep. 2023 Oct;50(4). doi: 10.3892/or.2023.8623. Epub 2023 Sep 1.
3
[Retracted] miR‑206 inhibits cancer initiating cells by targeting EHF in gastric cancer.[已撤回] miR-206通过靶向胃癌中的EHF抑制癌症起始细胞。
Oncol Rep. 2023 Nov;50(5). doi: 10.3892/or.2023.8634. Epub 2023 Sep 29.
4
[Retracted] MicroRNA‑381 serves as a prognostic factor and inhibits migration and invasion in non‑small cell lung cancer by targeting LRH‑1.[已撤回] 微小RNA-381作为一种预后因素,通过靶向肝受体同源物1抑制非小细胞肺癌的迁移和侵袭。
Oncol Rep. 2023 Nov;50(5). doi: 10.3892/or.2023.8640. Epub 2023 Oct 6.
5
[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.[已撤回] 川芎嗪通过下调叉头框蛋白M1抑制前列腺癌进展。
Oncol Rep. 2024 Nov;52(5). doi: 10.3892/or.2024.8811. Epub 2024 Sep 20.
6
[Retracted] MicroRNA‑219 is downregulated in non‑small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.[已撤回]MicroRNA-219在非小细胞肺癌中表达下调,并通过靶向HMGA2抑制细胞生长和转移。
Mol Med Rep. 2024 Jul;30(1). doi: 10.3892/mmr.2024.13237. Epub 2024 May 17.
7
[Retracted] AdipoR1‑mediated miR‑3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway.[已撤回] 脂联素受体1介导的miR-3908通过下调与AMPK/SIRT1途径相关的STAT2抑制胶质母细胞瘤的致瘤性。
Oncol Rep. 2024 Mar;51(3). doi: 10.3892/or.2024.8697. Epub 2024 Jan 8.
8
[Retracted] miR‑17‑5p promotes the growth of osteosarcoma in a BRCC2‑dependent mechanism.[已撤回] miR-17-5p通过一种依赖BRCC2的机制促进骨肉瘤生长。
Oncol Rep. 2024 Mar;51(3). doi: 10.3892/or.2024.8710. Epub 2024 Feb 1.
9
[Retracted] MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.[已撤回] 微小RNA-124-3p通过靶向信号转导和转录激活因子3抑制鼻咽癌细胞的生长和转移。
Oncol Rep. 2024 Nov;52(5). doi: 10.3892/or.2024.8807. Epub 2024 Sep 6.
10
[Retracted] miR‑187 inhibits the growth of cervical cancer cells by targeting FGF9.[已撤回] miR-187通过靶向FGF9抑制宫颈癌细胞的生长。
Oncol Rep. 2023 Nov;50(5). doi: 10.3892/or.2023.8632. Epub 2023 Sep 21.

[已撤回] 微小RNA-15b通过直接靶向金属蛋白酶组织抑制因子2促进非小细胞肺癌细胞的增殖和侵袭。

[Retracted] MicroRNA‑15b promotes proliferation and invasion of non‑small cell lung carcinoma cells by directly targeting TIMP2.

作者信息

Wang Haowen, Zhan Yu, Jin Jingjing, Zhang Chunhong, Li Wenfeng

机构信息

Department of Chemoradiotherapy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.

Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.

出版信息

Oncol Rep. 2023 Oct;50(4). doi: 10.3892/or.2023.8611. Epub 2023 Aug 18.

DOI:10.3892/or.2023.8611
PMID:37594085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10463006/
Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the cell migration and invasion images shown in Figs. 3B and D and 6C were strikingly similar to data that had already appeared in an article written by different authors at different research institutes [Liu C, Guan H, Wang Y, Chen M, Xu B, Zhang L, Lu K, Tao T and Zhang X: miR‑195 inhibits EMT by targeting FGF2 in prostate cancer cells. PLoS One 9: e0144073, 2015]. Owing to the fact that the contentious data in the above article had already been published prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 37: 3305‑3312, 2017; DOI: 10.3892/or.2017.5604].

摘要

在本文发表后,一位关注此事的读者提醒编辑注意,图3B、D和6C中所示的某些细胞迁移和侵袭图像与不同研究机构的不同作者撰写的一篇文章中已经出现的数据惊人地相似[Liu C, Guan H, Wang Y, Chen M, Xu B, Zhang L, Lu K, Tao T和Zhang X:miR-195通过靶向FGF2抑制前列腺癌细胞中的EMT。《公共科学图书馆·综合》9:e0144073,2015]。由于上述文章中有争议的数据在提交给本期刊之前就已经发表,编辑决定将本文从本期刊撤回。已要求作者对这些问题作出解释,但编辑部未收到答复。编辑就由此造成的不便向读者表示歉意。[《肿瘤学报道》37:3305 - 3312,2017;DOI:10.3892/or.2017.5604]